VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions

NCT02129933 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Dysplasia

Interventions

DRUG: Bevacizumab-IRDye800CW
DEVICE: Near infrared fluorescence endoscopy platform

Sponsor

University Medical Center Groningen